デフォルト表紙
市場調査レポート
商品コード
1396928

医療画像診断におけるAI市場:モダリティ別、技術別、用途別、業界別:世界の機会分析と産業予測、2023年~2032年

AI in Medical Imaging Market By Modality, By Technology (Deep Learning, Natural Language Processing, Computer Vision, Others), By Application, By Industry Vertical : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: | 発行: Allied Market Research | ページ情報: 英文 330 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
医療画像診断におけるAI市場:モダリティ別、技術別、用途別、業界別:世界の機会分析と産業予測、2023年~2032年
出版日: 2023年10月31日
発行: Allied Market Research
ページ情報: 英文 330 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療画像診断におけるAI市場規模は、2022年に18億9,112万米ドルと評価され、2023年から2032年までのCAGRは32.1%を記録し、2032年には297億5,483万米ドルに達すると予測されています。

医療用画像診断の人工知能市場は、人工知能とヘルスケア診断の破壊的な接合を提供し、医療用画像診断の実践に革命をもたらすと考えられています。この活況を呈する産業は、最新のAIアルゴリズムをX線、CT、MRI、超音波などの既存の医療画像モダリティとシームレスに統合することで、ヘルスケア診断と患者の転帰をかつてない高みへと導こうとしています。AIを活用した医療画像ソリューションは、画像解析、疾病診断、画像再構成、セグメンテーション、ワークフローの最適化など、幅広い用途をカバーしています。

本レポートの調査範囲では、主要企業が医療用画像処理におけるAI市場に参入する潜在的な機会について論じています。さらに、市場の詳細な分析を行い、現在の動向、主要な促進要因、主要な投資分野について概説しています。レポートには、業界の競合シナリオとバリューチェーンにおける各利害関係者の役割を理解するためのポーターのファイブフォース分析が含まれています。さらに、主要市場プレーヤーが市場での足場を維持するために採用した戦略についても特集しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 放射線学におけるAI利用の増加
      • AI搭載CTに対する需要の高まり
    • 抑制要因
      • 医療画像診断におけるAIのコスト上昇
    • 機会
      • AI企業による製品承認の獲得と資金調達の増加

第4章 医療画像診断におけるAI市場:モダリティ別

  • 概要
  • CTスキャン
  • MRI
  • X線
  • 超音波イメージング
  • 分子イメージング

第5章 医療画像診断におけるAI市場:技術別

  • 概要
  • ディープラーニング
  • 自然言語処理(NLP)
  • コンピュータビジョン
  • その他

第6章 医療画像診断におけるAI市場:用途別

  • 概要
  • 乳房イメージング
  • 呼吸器・肺
  • 神経
  • 整形外科
  • その他

第7章 医療画像診断におけるAI市場:業界別

  • 概要
  • 病院・ヘルスケアプロバイダー
  • 患者
  • 製薬・バイオテクノロジー企業
  • ヘルスケアペイヤー
  • その他

第8章 医療画像診断におけるAI市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ
    • ラテンアメリカ
    • 中東
    • アフリカ

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第10章 企業プロファイル

  • Siemens
  • NVIDIA Corporation
  • IBM Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Aidoc
  • Butterfly Network, Inc.
  • Zebra Technologies Corp.
  • Arterys Inc.
  • ICAD INC.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 02. AI IN MEDICAL IMAGING MARKET FOR CT SCAN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. AI IN MEDICAL IMAGING MARKET FOR MRI, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. AI IN MEDICAL IMAGING MARKET FOR X-RAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. AI IN MEDICAL IMAGING MARKET FOR ULTRASOUND IMAGING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. AI IN MEDICAL IMAGING MARKET FOR MOLECULAR IMAGING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 08. AI IN MEDICAL IMAGING MARKET FOR DEEP LEARNING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. AI IN MEDICAL IMAGING MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. AI IN MEDICAL IMAGING MARKET FOR COMPUTER VISION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. AI IN MEDICAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. AI IN MEDICAL IMAGING MARKET FOR BREAST IMAGING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. AI IN MEDICAL IMAGING MARKET FOR RESPIRATORY AND PULMONARY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. AI IN MEDICAL IMAGING MARKET FOR NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. AI IN MEDICAL IMAGING MARKET FOR ORTHOPEDICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. AI IN MEDICAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 19. AI IN MEDICAL IMAGING MARKET FOR HOSPITAL AND HEALTHCARE PROVIDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. AI IN MEDICAL IMAGING MARKET FOR PATIENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. AI IN MEDICAL IMAGING MARKET FOR PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. AI IN MEDICAL IMAGING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. AI IN MEDICAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. AI IN MEDICAL IMAGING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 29. NORTH AMERICA AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. U.S. AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 31. U.S. AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 32. U.S. AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. U.S. AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 34. CANADA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 35. CANADA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 36. CANADA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. CANADA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 51. ITALY AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 52. ITALY AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 53. ITALY AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ITALY AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 59. UK AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 60. UK AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 61. UK AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. UK AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 72. CHINA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 73. CHINA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 74. CHINA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. CHINA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 76. JAPAN AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 77. JAPAN AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 80. INDIA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 81. INDIA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. INDIA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. INDIA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH KOREA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH KOREA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 88. AUSTRALIA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 89. AUSTRALIA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 90. AUSTRALIA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. AUSTRALIA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 97. LAMEA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 98. LAMEA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. LAMEA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 100. LAMEA AI IN MEDICAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 101. LATIN AMERICA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 102. LATIN AMERICA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 103. LATIN AMERICA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. LATIN AMERICA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 105. MIDDLE EAST AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 106. MIDDLE EAST AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 107. MIDDLE EAST AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. MIDDLE EAST AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 109. AFRICA AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022-2032 ($MILLION)
  • TABLE 110. AFRICA AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 111. AFRICA AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. AFRICA AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022-2032 ($MILLION)
  • TABLE 113. SIEMENS: KEY EXECUTIVES
  • TABLE 114. SIEMENS: COMPANY SNAPSHOT
  • TABLE 115. SIEMENS: PRODUCT SEGMENTS
  • TABLE 116. SIEMENS: PRODUCT PORTFOLIO
  • TABLE 117. SIEMENS: KEY STRATERGIES
  • TABLE 118. NVIDIA CORPORATION: KEY EXECUTIVES
  • TABLE 119. NVIDIA CORPORATION: COMPANY SNAPSHOT
  • TABLE 120. NVIDIA CORPORATION: PRODUCT SEGMENTS
  • TABLE 121. NVIDIA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122. NVIDIA CORPORATION: KEY STRATERGIES
  • TABLE 123. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 124. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. IBM CORPORATION: SERVICE SEGMENTS
  • TABLE 126. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127. IBM CORPORATION: KEY STRATERGIES
  • TABLE 128. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 129. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 130. GE HEALTHCARE: SERVICE SEGMENTS
  • TABLE 131. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 132. GE HEALTHCARE: KEY STRATERGIES
  • TABLE 133. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 134. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 135. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
  • TABLE 136. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 137. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
  • TABLE 138. AIDOC: KEY EXECUTIVES
  • TABLE 139. AIDOC: COMPANY SNAPSHOT
  • TABLE 140. AIDOC: PRODUCT SEGMENTS
  • TABLE 141. AIDOC: PRODUCT PORTFOLIO
  • TABLE 142. AIDOC: KEY STRATERGIES
  • TABLE 143. BUTTERFLY NETWORK, INC.: KEY EXECUTIVES
  • TABLE 144. BUTTERFLY NETWORK, INC.: COMPANY SNAPSHOT
  • TABLE 145. BUTTERFLY NETWORK, INC.: PRODUCT SEGMENTS
  • TABLE 146. BUTTERFLY NETWORK, INC.: PRODUCT PORTFOLIO
  • TABLE 147. BUTTERFLY NETWORK, INC.: KEY STRATERGIES
  • TABLE 148. ZEBRA TECHNOLOGIES CORP.: KEY EXECUTIVES
  • TABLE 149. ZEBRA TECHNOLOGIES CORP.: COMPANY SNAPSHOT
  • TABLE 150. ZEBRA TECHNOLOGIES CORP.: SERVICE SEGMENTS
  • TABLE 151. ZEBRA TECHNOLOGIES CORP.: PRODUCT PORTFOLIO
  • TABLE 152. ARTERYS INC.: KEY EXECUTIVES
  • TABLE 153. ARTERYS INC.: COMPANY SNAPSHOT
  • TABLE 154. ARTERYS INC.: PRODUCT SEGMENTS
  • TABLE 155. ARTERYS INC.: PRODUCT PORTFOLIO
  • TABLE 156. ARTERYS INC.: KEY STRATERGIES
  • TABLE 157. ICAD INC.: KEY EXECUTIVES
  • TABLE 158. ICAD INC.: COMPANY SNAPSHOT
  • TABLE 159. ICAD INC.: PRODUCT SEGMENTS
  • TABLE 160. ICAD INC.: PRODUCT PORTFOLIO
  • TABLE 161. ICAD INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. AI IN MEDICAL IMAGING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF AI IN MEDICAL IMAGING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN AI IN MEDICAL IMAGING MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN AI IN MEDICAL IMAGING MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL AI IN MEDICAL IMAGING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. AI IN MEDICAL IMAGING MARKET, BY MODALITY, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR CT SCAN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR MRI, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR X-RAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR ULTRASOUND IMAGING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR MOLECULAR IMAGING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR DEEP LEARNING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR COMPUTER VISION, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. AI IN MEDICAL IMAGING MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR BREAST IMAGING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR RESPIRATORY AND PULMONARY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR ORTHOPEDICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL, 2022 AND 2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR HOSPITAL AND HEALTHCARE PROVIDERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 30. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR PATIENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 31. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 32. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR HEALTHCARE PAYERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 33. COMPARATIVE SHARE ANALYSIS OF AI IN MEDICAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 34. AI IN MEDICAL IMAGING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 35. U.S. AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CANADA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. FRANCE AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. GERMANY AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. ITALY AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SPAIN AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. UK AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF EUROPE AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. CHINA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. JAPAN AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. INDIA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. SOUTH KOREA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. AUSTRALIA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. REST OF ASIA-PACIFIC AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. LATIN AMERICA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. MIDDLE EAST AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 51. AFRICA AI IN MEDICAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 52. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 55. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 56. COMPETITIVE DASHBOARD
  • FIGURE 57. COMPETITIVE HEATMAP: AI IN MEDICAL IMAGING MARKET
  • FIGURE 58. TOP PLAYER POSITIONING, 2022
  • FIGURE 59. SIEMENS: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 60. SIEMENS: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 61. SIEMENS: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. SIEMENS: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. NVIDIA CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 64. NVIDIA CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. NVIDIA CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. NVIDIA CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 67. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 68. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 69. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. GE HEALTHCARE: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 72. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 74. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 75. BUTTERFLY NETWORK, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 76. BUTTERFLY NETWORK, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 77. BUTTERFLY NETWORK, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 78. BUTTERFLY NETWORK, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 79. ZEBRA TECHNOLOGIES CORP.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 80. ZEBRA TECHNOLOGIES CORP.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 81. ZEBRA TECHNOLOGIES CORP.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 82. ZEBRA TECHNOLOGIES CORP.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 83. ICAD INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 84. ICAD INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 85. ICAD INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
目次
Product Code: A12693

The AI in medical imaging market size was valued at $1,891.12 million in 2022, and is projected to reach $29,754.83 million by 2032, registering a CAGR of 32.1% from 2023 to 2032.

The artificial intelligence in medical imaging market provides a disruptive junction of artificial intelligence and healthcare diagnostics that is set to revolutionize medical imaging practices. This booming industry aspires to take healthcare diagnostics and patient outcomes to unprecedented heights by seamlessly integrating modern AI algorithms with existing medical imaging modalities such as X-ray, CT, MRI, and ultrasound. AI-powered medical imaging solutions cover a wide variety of applications, such as image analysis, illness diagnosis, picture reconstruction, segmentation, and workflow optimization.

The scope of the report discusses the potential opportunities for the key players to enter the AI in medical imaging market. Furthermore, it provides an in-depth analysis of the market, outlining current trends, key driving factors, and key areas of investment. The report includes Porter's five forces analysis to understand the competitive scenario of the industry and role of each stakeholder in the value chain. Moreover, it features the strategies adopted by key market players to maintain their foothold in the market.

The AI in medical imaging market is segmented on the basis of modality, technology, application, industry vertical and region. On the basis of modality, it is classified into CT Scan, MRI, X-rays, Ultrasound Imaging and Molecular Imaging. On the basis of technology, it is classified into Deep Learning, Natural Language Processing (NLP), Computer Vision, and others. On the basis of application, it is classified into Breast Imaging, Respiratory and Pulmonary, Neurology, Orthopedics, and others. On the basis of industry vertical, it is classified into Hospital and Healthcare Providers, Patients, Pharmaceuticals and Biotechnology Companies, Healthcare Payers, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Several factors are driving the AI in medical imaging market, with one of them being the increasing use of AI in radiology. AI's capacity to quickly and accurately analyze medical pictures has improved diagnostic capabilities and shortened procedures. AI-assisted image interpretation benefits radiologists by assisting in the detection of minor anomalies, early illness diagnosis, and personalized therapy planning. This has led to better patient outcomes, a reduction in diagnostic blunders, and optimal resource use. Another driving factor is the rise in demand for AI-powered CT. A tremendous increase in demand for AI-powered Computed Tomography (CT) has been seen in recent years, driven by the technology's revolutionary effects on diagnostics and healthcare. Radiologists and physicians are now able to spot minor irregularities, complex tissue structures, and possible problems that could have gone unnoticed using conventional techniques thanks to AI algorithms that analyze CT images with unmatched speed and precision.

On the other hand, the rise in costs is hampering the market. The market for AI in medical imaging has been significantly constrained by the rising cost of implementation. While AI has shown incredible promise in improving patient care, treatment planning, and diagnostic accuracy, its adoption comes with a hefty price tag that presents difficulties for healthcare organizations and providers.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ai in medical imaging market analysis from 2022 to 2032 to identify the prevailing ai in medical imaging market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ai in medical imaging market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ai in medical imaging market trends, key players, market segments, application areas, and market growth strategies.
  • The key players operating in the AI in medical imaging market are Siemens, NVIDIA Corporation, IBM Corporation, GE Healthcare, Koninklijke Philips N.V., Aidoc, Butterfly Network, Inc., Zebra Technologies Corp., Arterys Inc., and ICAD Inc. These key players adopt several strategies such as new product launch and development, acquisition, partnership and collaboration and business expansion to increase their market share in the global AI in medical imaging market during the forecast period.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Investment Opportunities
  • Product Life Cycles
  • Go To Market Strategy
  • Pain Point Analysis
  • Regulatory Guidelines
  • Criss-cross segment analysis- market size and forecast
  • Historic market data

Key Market Segments

By Modality

  • CT Scan
  • MRI
  • X-rays
  • Ultrasound Imaging
  • Molecular Imaging

By Technology

  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Others

By Application

  • Breast Imaging
  • Respiratory and Pulmonary
  • Neurology
  • Orthopedics
  • Others

By Industry Vertical

  • Hospital and Healthcare Providers
  • Patients
  • Pharmaceuticals and Biotechnology Companies
  • Healthcare Payers
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Key Market Players:

    • Koninklijke Philips N.V.
    • Siemens
    • NVIDIA Corporation
    • GE Healthcare
    • ICAD INC.
    • Aidoc
    • Butterfly Network, Inc.
    • IBM Corporation
    • Zebra Technologies Corp.
    • Arterys Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in use of AI in Radiology
      • 3.4.1.2. Rise in demand for AI-powered CT
    • 3.4.2. Restraints
      • 3.4.2.1. Rise in costs of AI in Medical Imaging
    • 3.4.3. Opportunities
      • 3.4.3.1. Gain in product approvals and more funding from AI companies

CHAPTER 4: AI IN MEDICAL IMAGING MARKET, BY MODALITY

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. CT Scan
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. MRI
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. X-rays
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Ultrasound Imaging
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Molecular Imaging
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: AI IN MEDICAL IMAGING MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Deep Learning
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Natural Language Processing (NLP)
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Computer Vision
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: AI IN MEDICAL IMAGING MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Breast Imaging
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Respiratory and Pulmonary
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Neurology
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Orthopedics
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country
  • 6.6. Others
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by region
    • 6.6.3. Market share analysis by country

CHAPTER 7: AI IN MEDICAL IMAGING MARKET, BY INDUSTRY VERTICAL

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospital and Healthcare Providers
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Patients
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Pharmaceuticals and Biotechnology Companies
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Healthcare Payers
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country
  • 7.6. Others
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by region
    • 7.6.3. Market share analysis by country

CHAPTER 8: AI IN MEDICAL IMAGING MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Modality
    • 8.2.3. Market size and forecast, by Technology
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by Industry Vertical
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Modality
      • 8.2.6.1.2. Market size and forecast, by Technology
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by Industry Vertical
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Modality
      • 8.2.6.2.2. Market size and forecast, by Technology
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by Industry Vertical
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Modality
    • 8.3.3. Market size and forecast, by Technology
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by Industry Vertical
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. France
      • 8.3.6.1.1. Market size and forecast, by Modality
      • 8.3.6.1.2. Market size and forecast, by Technology
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by Industry Vertical
      • 8.3.6.2. Germany
      • 8.3.6.2.1. Market size and forecast, by Modality
      • 8.3.6.2.2. Market size and forecast, by Technology
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by Industry Vertical
      • 8.3.6.3. Italy
      • 8.3.6.3.1. Market size and forecast, by Modality
      • 8.3.6.3.2. Market size and forecast, by Technology
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by Industry Vertical
      • 8.3.6.4. Spain
      • 8.3.6.4.1. Market size and forecast, by Modality
      • 8.3.6.4.2. Market size and forecast, by Technology
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by Industry Vertical
      • 8.3.6.5. UK
      • 8.3.6.5.1. Market size and forecast, by Modality
      • 8.3.6.5.2. Market size and forecast, by Technology
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by Industry Vertical
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Modality
      • 8.3.6.6.2. Market size and forecast, by Technology
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by Industry Vertical
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Modality
    • 8.4.3. Market size and forecast, by Technology
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by Industry Vertical
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. China
      • 8.4.6.1.1. Market size and forecast, by Modality
      • 8.4.6.1.2. Market size and forecast, by Technology
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by Industry Vertical
      • 8.4.6.2. Japan
      • 8.4.6.2.1. Market size and forecast, by Modality
      • 8.4.6.2.2. Market size and forecast, by Technology
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by Industry Vertical
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Modality
      • 8.4.6.3.2. Market size and forecast, by Technology
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by Industry Vertical
      • 8.4.6.4. South Korea
      • 8.4.6.4.1. Market size and forecast, by Modality
      • 8.4.6.4.2. Market size and forecast, by Technology
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by Industry Vertical
      • 8.4.6.5. Australia
      • 8.4.6.5.1. Market size and forecast, by Modality
      • 8.4.6.5.2. Market size and forecast, by Technology
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by Industry Vertical
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Modality
      • 8.4.6.6.2. Market size and forecast, by Technology
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by Industry Vertical
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Modality
    • 8.5.3. Market size and forecast, by Technology
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by Industry Vertical
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Latin America
      • 8.5.6.1.1. Market size and forecast, by Modality
      • 8.5.6.1.2. Market size and forecast, by Technology
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by Industry Vertical
      • 8.5.6.2. Middle East
      • 8.5.6.2.1. Market size and forecast, by Modality
      • 8.5.6.2.2. Market size and forecast, by Technology
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by Industry Vertical
      • 8.5.6.3. Africa
      • 8.5.6.3.1. Market size and forecast, by Modality
      • 8.5.6.3.2. Market size and forecast, by Technology
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by Industry Vertical

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Siemens
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. NVIDIA Corporation
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. IBM Corporation
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
    • 10.3.7. Key strategic moves and developments
  • 10.4. GE Healthcare
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
    • 10.4.7. Key strategic moves and developments
  • 10.5. Koninklijke Philips N.V.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
    • 10.5.7. Key strategic moves and developments
  • 10.6. Aidoc
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Key strategic moves and developments
  • 10.7. Butterfly Network, Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. Zebra Technologies Corp.
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
  • 10.9. Arterys Inc.
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Key strategic moves and developments
  • 10.10. ICAD INC.
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments